Article
Multicenter Evaluation of the VERSANT Hepatitis B Virus DNA 3.0 Assay
1 Feb 2004
Abstract excerpt
The VERSANT hepatitis B virus (HBV) 3.0 Assay (branched DNA [bDNA]) (referred to herein as VERSANT 3.0) was evaluated at four external sites for analytical sensitivity, specificity, reproducibility, linearity of quantification, and limits of detection. In addition, each of the test evaluation sites provided HBV DNA-positive clinical samples that were previously analyzed by one of three commercially available HBV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
